Identifying Heart, Lung, and Blood Disease-Causing Variants

by: TopGovernmentGrants Editorial Staff

The National Institutes of Health, otherwise known as NIH, is the agency operating within the United States Department of Health and Human Services that is fundamentally responsible for all of the country's biomedical and health-related research studies.

The programs and objectives of the NIH are tailored to contribute to the achievement of their agency mission, which is to "seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce the burdens of illness and disability."

In keeping with this mission, the National Institutes of Health has formed a partnership with the National Heart, Lung, and Blood Institute to establish a program that aims to Identify Heart, Lung, and Blood Disease-Causing Variants.

The Identifying Heart, Lung, and Blood Disease-Causing Variants Program aims to follow suit to research studies that intend to identify heart, lung, and blood disease-causing rare or lower frequency variants through the use of the extensive exome data that was discovered under the Recovery and Reinvestment Act of 2009.

The organizers of the program believe that this data will enable lung, heart and blood investigators, to focus on variants, genes, and pathways that could potentially lead them to a deeper and more thorough understanding of certain complex diseases.

  (continued...)

Identifying Heart, Lung, and Blood Disease-Causing Variants
  Page 2

About The Author The TopGovernmentGrants Editorial Staff maintains one the most comprehensive Websites offering information on government grants and federal government programs. The staff also provides resources to other Websites with information on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

2012 Tuberous Sclerosis Complex Clinical Trial Award Program
In line with this mission, the United States Department of Defense has recently established the 2012 Tuberous Sclerosis Complex Clinical Trial Award Program in an attempt to financially support the studies regarding the promotion innovative research focused on decreasing the clinical impact of tuberous sclerosis complex (TSC).

---

Advanced Neural Prosthetics Research and Development Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to establish the Advanced Neural Prosthetics Research and Development Program.

---

HIV Innovations for Improved Patient Outcomes for Priority Populations Program
The United States Agency for International Development in South Africa has recently established the HIV Innovations for Improved Patient Outcomes for Priority Populations Program wherein it intends to solicit applications coming from local organizations which are interested in heading the implementation of a five-year plan centered on the program in focus.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---